ARCHIVES

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Double Trouble For NIH: Democrats Offer Small Increases, Bush May Veto The Bill.

July 6, 2007

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 12, 1990

In Brief: Four To Share In $100,000 Hammer Prize; Oldham To Head New Genetic Engineering Firm In Texas

February 3, 1984

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

DCBDC Advisors Table Gl SPORE Over Pancreatic Cancer Research Requirement

March 17, 1995

AACR Plans Office in Singapore.

November 30, 2007